Cargando…
β(2 )adrenergic agonists in acute lung injury? The heart of the matter
Despite extensive research into its pathophysiology, acute lung injury/acute respiratory distress syndrome (ALI/ARDS) remains a devastating syndrome with mortality approaching 40%. Pharmacologic therapies that reduce the severity of lung injury in vivo and in vitro have not yet been translated to ef...
Autor principal: | Lee, Jae W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811950/ https://www.ncbi.nlm.nih.gov/pubmed/20017898 http://dx.doi.org/10.1186/cc8171 |
Ejemplares similares
-
Body‐weight‐independent glucose‐lowering effect of the β3‐adrenergic receptor agonist mirabegron in humans
por: Waki, Hironori, et al.
Publicado: (2021) -
Effect of beta-adrenergic agonist on alveolar fluid clearance in rats with acute lung injury
por: Qiu, H, et al.
Publicado: (2005) -
Agonist-Directed Desensitization of the β(2)-Adrenergic Receptor
por: Goral, Vasiliy, et al.
Publicado: (2011) -
β-agonists for ARDS: the dark side of adrenergic stimulation?
por: Thompson, B Taylor
Publicado: (2012) -
Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)